Retractable Technologies, Inc. is a U.S.-based medical device company specializing in the design, development and manufacture of safety-engineered injection technologies aimed at reducing needlestick injuries. Headquartered in Little Elm, Texas, Retractable Technologies offers proprietary needle retraction systems that automatically withdraw the needle into the syringe barrel immediately after use, thereby enhancing safety for healthcare workers and patients.
The company’s flagship product, VanishPoint®, features a one-handed, automatic retraction mechanism and is available in multiple configurations, including standard syringes and Luer-lock fittings. In addition to auto-retractable syringes, Retractable Technologies markets a range of safety infusion sets and catheter insertion devices under its SafePoint® brand, all engineered to meet stringent regulatory standards and facilitate compliance with global needlestick prevention guidelines.
Founded in the late 1990s, Retractable Technologies was incorporated in Delaware and subsequently established a manufacturing facility in Texas to support its in-house production and quality assurance processes. The company is led by founder and chief executive officer Michael J. Krahling, whose vision has guided Retractable’s focus on continuous product refinement and expansion of its intellectual property portfolio. Over the years, Retractable has secured distribution agreements across North America and select international markets to broaden the accessibility of its safety devices.
Retractable Technologies maintains quality management systems certified to ISO 13485 standards and collaborates with healthcare providers, group purchasing organizations and distributors to promote the adoption of needlestick prevention products. With ongoing investments in research and development, the company seeks to enhance device ergonomics and functionality while adhering to evolving healthcare regulations and standards worldwide.
AI Generated. May Contain Errors.
